Antithrombin supplementation during extracorporeal membrane oxygenation: study protocol for a pilot randomized clinical trial

BACKGROUND: Normal levels of plasma antithrombin (AT) activity might decrease heparin requirements to achieve an adequate level of anticoagulation during treatment with extracorporeal membrane oxygenation (ECMO). Acquired AT deficiency during ECMO is common, but formal recommendations on target, tim...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Trials
Hoofdauteurs: Panigada, Mauro, Spinelli, Elena, Cucino, Alberto, Cipriani, Elisa, De Falco, Stefano, Panarello, Giovanna, Occhipinti, Giovanna, Arcadipane, Antonio, Sales, Gabriele, Fanelli, Vito, Brazzi, Luca, Novembrino, Cristina, Consonni, Dario, Pesenti, Antonio, Grasselli, Giacomo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2019
Onderwerpen:
Study Protocol
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6558738/
https://ncbi.nlm.nih.gov/pubmed/31186035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3386-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items